<DOC>
	<DOCNO>NCT00235573</DOCNO>
	<brief_summary>Vitamin B12 essential nutrient body need cell divide function normally . Individuals may develop deficiency vitamin B12 either limit amount diet decrease vitamin B12 intake body ( absorption ) . Keeping adequate B12 blood level important health . Vitamin B12 deficiency may increase one 's risk develop anemia even lead neurological problem paralysis deficiency severe last long time . It important doctor accurate test determine people absorb vitamin B12 normally treatment start severe clinical problem occur . The purpose research provide new information may help scientist develop good method test problem absorb vitamin B12 . In study , change amount vitamin B12 bound protein ( transcobalamin ) blood measure dos vitamin B12 take . If amount vitamin B12-protein complex ( call holo-transcobalamin ) change response take vitamin B12 supplement normal individual , may possible use information develop new sensitive test identify individual problem absorb vitamin B12 . This new vitamin B12 absorption test may better clinical test vitamin B12 absorption available doctor use .</brief_summary>
	<brief_title>Evaluation Holotranscobalamin Indicator Vitamin B12 Absorption</brief_title>
	<detailed_description>Part I Screening : Individuals meet initial screen criterion schedule fast blood sample draw General Clinical Research Center ( GCRC ) . All participant sign inform consent form approve UF Institutional Review Board prior initiation part study . Subjects ' height weight measure subject ask complete medical history questionnaire . Blood analysis include serum B12 , blood chemistry , hematological index . Females give pregnancy test . Subjects eligible Part II study ( Intervention ) serum B12 concentration ≥444 pmol/L ; non-anemic ; normal general blood chemistry ( value within near normal range ) , history chronic disease ( e.g. , pernicious anemia , cancer , diabetes , renal disease , hypertension , neurological abnormality , gastrointestinal disorder ) . Any subject deficient ( &lt; 148 pmol/L ) serum B12 concentration [ 18 ] eligible participation instruct see personal physician complete follow-up treatment . Part II Intervention : Changes B12 status assessment indicator response B12 supplementation evaluate . Subjects come GCRC night ( Day 1 ) intervention protocol . The next morning ( Day 1 ) follow overnight fast , indwell catheter insert repeat blood sample draw throughout Day 1 . A baseline fast blood sample ( # 1 ) drawn . Subjects consume light breakfast ( include 1 piece bread 8 oz orange juice ) take 9 ug dose B12 ( Dose 1 ) . Thirty minute completion meal consumption B12 supplement , second blood sample ( # 2 ) drawn . Five subsequent hourly blood sample ( # 3-7 ) drawn . After 7th blood sample subject consume one piece bread 8 ounce orange juice take second 9 ug dose B12 ( Dose 2 ) blood sample ( # 8 ) drawn 30 minute consumption meal B12 dose . Five subsequent hourly blood sample ( # 9-13 ) drawn . The subject consume one piece bread 8 ounce orange juice take 9 ug dose B12 ( Dose 3 ) . Another blood sample ( # 14 ) drawn 30 minute meal B12 dose . One hour later , final ( Day 1 ) blood sample ( # 15 ) drawn follow removal catheter . In addition bread juice consume B12 supplement , subject receive mid-morning snack 2 hour Dose 1 B12 supplement , lunch 3.5 hr Dose 1 B12 supplement , dinner 4 hour Dose 2 B12 supplement , even snack 3 hour Dose 3 . Low B12-containing food provide GCRC . Water non-caffeinated , non-caloric beverage allow ad libitum . The subject remain GCRC overnight fast blood sample ( # 16 ) drawn morning Day 2 . On Day 2 participant provide breakfast follow blood draw , free leave GCRC . Subjects provide take-away meal snack ( lunch , dinner , snack ) consist low-B12 contain food . Subjects instructed return morning Day 3 time one fasting blood sample ( # 17 ) drawn provide breakfast leave GCRC . All overnight fast 10 pm previous night . The following B12 indicator measure blood draw ( ) holo-TC ; ( b ) total-TC ; ( c ) holo-HC total HC ; ( ) serum B12 ; ( e ) plasma albumin . Additional B12 status indicator ( e.g . homocysteine , methylmalonic acid , RBC B12 ) measure select blood draw interval . A baseline folate analysis do .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>No vitamin B12containing supplement use within past year No vitamin B12 injection within past year No use tobacco product No chronic use prescription medication except oral contraceptive No history chronic disease ( e.g. , pernicious anemia , cancer , diabetes , renal disease , hypertension , neurological abnormality , gastrointestinal disorder ) BMI 18.529.9 General Chemistry Blood Tests ( value within near normal range ; hemoglobin female ≥ 11.0 g/dL ; male ≥ 12 g/dL ) B12 status ( Serum B12 ≥ 444 pmol/L ) Capable understanding inform consent form Agrees comply protocol requirement History pernicious anemia , cancer , diabetes , renal disease , hypertension , heart disease , neurological abnormality , gastrointestinal disorder , lung disease , hepatic disease , hematologic , metabolic disease , opinion CoPrincipal Investigators , would affect safety compliance Vitamin B12 supplement use injection within past year Pregnant breast feeding Has BMI &lt; 18.5 &gt; 29.9 Has donate lose significant volume ( &gt; 450 mL ) blood plasma within 30 day study General chemistry lab value outside range Serum B12 outside range list Use tobacco product Chronic use prescription medication except oral contraceptive Does understand inform consent form Does agree comply protocol requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Vitamin B12 absorption</keyword>
	<keyword>Holo-transcobalamin</keyword>
</DOC>